Delivery Order SPE2DR25D2014-SPE2DR26FZ93W
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,790.18 on December 4, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with an ultimate completion date of December 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $21,707.66 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Trulicity 3 mg/0.5 ml pens. This competitively awarded, firm fixed-price contract has an ultimate completion date of December 5, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Trulicity 3 mg/0.5 mL pens valued at $1,201.20 with a completion date of September 30, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,744.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL) on December 4, 2025, with an ultimate completion date of December 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 25, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $1,453.70. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 26, 2025, and will be performed at the awardee's facility in Conshohocken, PA. The award represents a child order under...
- The Defense Logistics Agency awarded a delivery order valued at $1,162.96 to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on December 9, 2025, with completion scheduled for December 10, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical supply transaction under the company's existing indefinite delivery contract with DLA Troop Support Medical. The award is not designated as a set-aside contract and will be performed at...
- The Defense Logistics Agency awarded a $1,767.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Trulicity 3 mg/0.5 ml pens. The contract, which represents a non-set-aside competitive award, is scheduled for ultimate completion by August 18, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,657.20 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on December 10, 2025, with completion scheduled for December 11, 2025. This competitively awarded, firm fixed-price contract requires performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,744.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on a firm fixed-price basis. The contract was executed on December 11, 2025, with an ultimate completion date of December 12, 2025, and represents a non-set-aside competitive award. Performance will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,239.95 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on December 9, 2025, with a completion date of December 10, 2025. This firm fixed price, non-set-aside contract represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ93WDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Trulicity 3 mg/0.5 mL pens valued at $1,744.44 with an ultimate completion date of December 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as the primary pharmaceutical supply vehicle for military healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing a comprehensive range of medical products to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements, from specialty medications and brand-name drugs to vaccines and medical supplies across multiple therapeutic domains. The SPE2DX contract enables the company to support military healthcare programs globally, with the DLA planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts involving multiple regional awards among different contractors in the coming years.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/9/25 |